AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MeVis Medical Solutions AG

Earnings Release Aug 21, 2025

287_rns_2025-08-21_c97857f7-85eb-4bf3-9690-db73a8c15d1d.html

Earnings Release

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 21 August 2025 17:45

MeVis Medical Solutions AG: Forecast adjustment for the 2024/2025 fiscal year

MeVis Medical Solutions AG / Key word(s): Change in Forecast

MeVis Medical Solutions AG: Forecast adjustment for the 2024/2025 fiscal year

21-Aug-2025 / 17:45 CET/CEST

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group.

The issuer is solely responsible for the content of this announcement.


Bremen, August 21, 2025 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, is adjusting its forecast for the current fiscal year based on preliminary figures for the first ten months.

For fiscal year 2024/2025 (October 1, 2024 to September 30, 2025), revenue is now expected to decline slightly to between €16.5 million and €17.0 million (previous forecast: €17.0 million to €17.5 million). MeVis expects EBIT (earnings before interest and taxes) to decline to between €3.0 million and €3.5 million (previous forecast: €3.5 million to €4.0 million).

License sales are below expectations and cannot be offset by maintenance revenues and other revenues.

************************************************************************

Contact:

Kirchhoff, Marcus / CEO

End of Inside Information


21-Aug-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com


Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: [email protected]
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2187294
End of Announcement EQS News Service

2187294  21-Aug-2025 CET/CEST

Talk to a Data Expert

Have a question? We'll get back to you promptly.